South Korea has officially requested that the US take a distinct approach in its ongoing probe into foreign semiconductor technology and related dow...
May 07, 2025 (Gmt+09:00)
South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...
Apr 28, 2025 (Gmt+09:00)
South Korea’s processed food exports to India have surged to a record 6 trillion won ($4.1 billion), marking a significant milestone in the gr...
Apr 18, 2025 (Gmt+09:00)
South Korea’s biopharmaceutical giant Celltrion Inc. has solidified its presence in South America after winning supply contracts for its flags...
Apr 17, 2025 (Gmt+09:00)
The South Korean defense industry's current heyday is expected to continue for a while as global demand for Korean-made weapons and combat systems h...
Apr 15, 2025 (Gmt+09:00)
South Korea’s National Pension Service, the country’s largest institutional investor, has come to the rescue of the domestic stock marke...
Apr 14, 2025 (Gmt+09:00)
South Korea’s National Pension Service (NPS), the country’s largest institutional investor, is set to overhaul its investment strategy w...
Apr 11, 2025 (Gmt+09:00)
South Korean shipbuilding stocks soared on Friday on news that US President Donald Trump indicated that the world’s No. 1 economy may purchase...
Apr 11, 2025 (Gmt+09:00)
Spot, a quadruped robot developed by Boston Dynamics Inc., will aid defense and safety agencies in Australia, New Zealand and Indonesia to assist in...
Apr 10, 2025 (Gmt+09:00)
Celltrion Inc. said Wednesday it has received regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for three biosimilar...
Apr 10, 2025 (Gmt+09:00)
It is time to shift focus toward non-US markets after years of stellar performance of US assets driven by the robust world’s No. 1 economy, sa...
Apr 02, 2025 (Gmt+09:00)
Orchestra Private Equity has begun the process of divesting the South Korean operations of fast-food chain KFC, which has seen earnings growth since...
Apr 02, 2025 (Gmt+09:00)
South Korea’s Constitutional Court on Friday will give its ruling on President Yoon Suk Yeol, who was impeached in December for declaring mart...
Apr 01, 2025 (Gmt+09:00)
South Korea’s leading biosimilar drug developer Celltrion Inc. said on Monday it is set to sell Steqeyma, a biosimilar to autoimmune disease t...
Mar 25, 2025 (Gmt+09:00)
South Korea’s top and third-ranked food delivery apps, Baedal Minjok (Baemin) and Yogiyo, saw their biggest-ever monthly drops in transaction ...
Mar 24, 2025 (Gmt+09:00)
WASHINGTON, D.C. – The US government plans to unveil country-specific reciprocal tariffs on April 2, with particular attention to nations impo...
Mar 19, 2025 (Gmt+09:00)
South Korean biotechnology firm SillaJen Inc. is pioneering a new approach to determine the best dose for a cancer drug combination in clinical tria...
Mar 18, 2025 (Gmt+09:00)
Samsung Group companies will jointly invest $10 million in C2N Diagnostics LLC, a U.S.-based company specializing in blood-based Alzheimer’s d...
Mar 13, 2025 (Gmt+09:00)
South Korea’s National Pension Service (NPS), the nation’s biggest institutional investor, could lose more than 1 trillion won ($692 mil...
Mar 07, 2025 (Gmt+09:00)
Chong Kun Dang Pharmaceutical Corp. is discussing building a research center and a plant in Siheung, about 30 kilometers southwest of Seoul, with th...
Feb 27, 2025 (Gmt+09:00)
Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...
Feb 25, 2025 (Gmt+09:00)